GGrantIndex
Sort

130,381 grants matching hiv

Human Tissue and Organ Research Resource

$1,529,937
John T Lonsdale · National Disease Research Interchange · U42 · FY2011 · RR

Developmental Core

$1,529,875
Richard T D'aquila · Northwestern University At Chicago · P30 · FY2020 · AI

Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

$1,529,375
Yukari C Manabe · Johns Hopkins University · U54 · FY2020 · EB

Human Tissue and Organ Research Resource

$1,529,243
John T Lonsdale · National Disease Research Interchange · U42 · FY2012 · OD

Project 2

$1,529,213
Alan D Frankel · University Of California, San Francisco · U54 · FY2023 · AI

Vaccine development and production

$1,529,201
Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2022 · AI

Effects of genetic polymorphism in MHC, KIR, and related loci on human disease

$1,528,756
Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

PItt-Ohio State-Georgetown Clinical Trials Unit

$1,528,540
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2018 · AI

Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research

$1,528,493
Michael K Axthelm · Oregon Health & Science University · U42 · FY2017 · OD

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.

$1,528,344
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2023 · AI

Human genetics of TB resistance in HIV-infected persons

$1,528,106
Erwin Schurr · Mcgill University Health Ctr Res Inst · R01 · FY2016 · AI

Host Defense Against HIV-related Pulmonary Infections

$1,528,062
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2006 · HL

REDUCING NEW HIV INFECTIONS IN BONJANALA PLATINUM , N.W. PROVINCE OF S. AFRICA

$1,528,034
Scott Barnhart · University Of Washington · U2G · FY2013 · GH

PS07-768, Expanded and Integrated HIV Testing for Populations Disproportionately

$1,528,000
Carmine Grasso · New Jersey State Dept/Health/Senior Srvs · U62 · FY2007 · PS

UCSF Prevention Research Center

$1,527,900
Marguerita A Lightfoot · University Of California, San Francisco · U48 · FY2016 · DP

LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK

$1,527,881
University Of Alabama At Birmingham · U01 · FY2003 · HD

Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease

$1,527,723
Steven J. Schiff · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · AI

ETIB Clinical Research Core

$1,527,560
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2016 · CA

Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men

$1,527,538
H. Jonathon Rendina · Hunter College · UG3 · FY2018 · AI

NIAID- VRC- Evaluating mRNA Vaccine Candidates and Capability Development

$1,527,328
Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI

PS09-962: SUPP. THE IMP. AND EXPANSION OF HIGH QUALITY HIV PREVENTION,CARE A

$1,527,321
Dr. Anthony Amoroso · University Of Maryland Baltimore · U2G · FY2014 · PS

NEUROAIDS--EFFECTS OF METHAMPHETAMINE

$1,527,273
University Of California San Diego · P01 · FY2003 · DA

Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV

$1,527,174
Christine Cheng · University Of California, San Diego · U01 · FY2023 · DA

Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy

$1,527,040
Richard T D'aquila · Northwestern University At Chicago · P01 · FY2020 · AI

Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine

$1,526,960
Mary E. Klotman · Duke University · P01 · FY2019 · AI